CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,487 | -50.6% | 187,800 | -25.2% | 0.00% | – |
| Q4 2022 | $164,838 | -24.4% | 251,200 | -0.8% | 0.00% | – |
| Q3 2022 | $218,000 | +65.2% | 253,351 | +5.3% | 0.00% | – |
| Q2 2022 | $132,000 | -17.0% | 240,500 | +68.2% | 0.00% | – |
| Q1 2022 | $159,000 | -71.5% | 143,000 | -55.8% | 0.00% | – |
| Q4 2021 | $557,000 | -36.2% | 323,734 | +13.9% | 0.00% | – |
| Q3 2021 | $873,000 | -11.5% | 284,284 | +12.5% | 0.00% | – |
| Q2 2021 | $986,000 | +916.5% | 252,793 | +630.1% | 0.00% | – |
| Q1 2021 | $97,000 | +34.7% | 34,626 | +193.4% | 0.00% | – |
| Q3 2020 | $72,000 | -97.5% | 11,800 | -95.0% | 0.00% | -100.0% |
| Q3 2019 | $2,841,000 | -16.9% | 234,409 | -21.5% | 0.00% | -50.0% |
| Q2 2019 | $3,418,000 | – | 298,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |